Portfolio Finder

NovaPump GmbH is developing and realising a leading solution for a novel right ventricular assist device (RVAD) with clear USPs (the only percutaneous device with pulsatile support).
NovaPump’s catheter-based heart pump PERKAT™ can be implanted within minutes in acute situations involving acute right heart failure, cardiogenic shock or acute right heart insufficiency and offers highly efficient pulsatile heart support in combination with the existing IABP (Intra-Aortic Balloon Pump) technology as a drive.
A perspective application of PERKAT™ as a bi-ventricular assist device (bi-VAD) is also planned for the near future.

Novum offers through AI and a hardware module exact battery monitoring that enables 15% more capacity usage and 20% longer lifetime. The on-site instant battery characterisation enables multiple second-life use cases for batteries with a strong sustainability impact and increased safety against fire or explosions.

Numaferm developed a platform technology for fast, scalable and cost-efficient production of peptides and proteins, with a focus on pepteins (PEPTides & protEINS) in the range of 30-500 amino acids. They serve customers from pharma, biotech, agriculture, and cosmetics offering peptides and proteins at highest qualities, within weeks, in a sustainable way. In this context partnership deals with global CDMO PolyPeptide and the world’s leading animal health company Zoetis were closed.
Founded in 2017 as a spin-out of Düsseldorf University, Numaferm has grown to over 20 staff.

NYRIS provides a state-of-the-art image and object recognition engine using latest Artificial Intelligence frameworks. The unique concept delivers very accurate results for 1D (codes), 2D (print2web) and 3D (real world products) typically below one second. The solution is available „as-a-service“ for both retail and industry customers.

OMEICOS Therapeutics develops a novel, first-in-class, small molecule drug addressing a new Mode of Action for the treatment and prevention of atrial fibrillation.

oncgnostics develops - based on proprietary epigenetic biomarkers - highly reliable molecular in-vitro diagnostic (IVD) tests for screening, follow-up care and therapeutic decisions in oncology.

ondeso develops software specifically in the fields industry 4.0 and digitalisation. No matter whether the client is a production company or a machine manufacturer, a medium sized business or a corporate group – ondeso supports them specifically in the field of IT operating management and security in production. The successfully launched products are suited for all industries and applicable across the entire range of production systems and procedures. Whether management systems, HMIs or controls – ondeso manages the lifecycle of industry PCs and offers custom fitted products on the highest technological and conceptual level - 100% made in Germany

OrbEx is an innovative space access company.

PAUL SECRET Outfittery takes the pain out of shopping for men by providing the first personal shopping service for customers, who want to be dressed well, but hate shopping.

PANDA is a spin-off of the Helmut Schmidt University/University of the German Armed Forces in Hamburg with focus on Industrial AI. Founded in July 2018, the start-up has set itself the goal of securing the competitiveness of German engineering industry. With PANDA | DRIFT, PANDA offers an AI system for minimizing performance deficits in industrial production. The basis for this is a self-developed Machine Learning Framework, which has been optimized for industrial use by a combination of hardware and software. This enables the automatic identification of causes for production problems and the setting of optimal production parameters. The data-driven approach using artificial intelligence, enables automated process optimization and monitoring for the industry which is just right for the current era.

Pantherna Therapeutics is a privately-held biopharmaceutical company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is based on advanced nanoparticles for the delivery and expression of therapeutic mRNA drugs in the endothelium. Pantherna is based in Hennigsdorf (Brandenburg) close to Berlin, Germany.

payever was founded to make commerce easier for businesses of all types and sizes. The company provides a modular SaaS solution to sell everywhere and accept all payments.

PEPperPRINT produces customized ultra-high density peptide microarrays and uses individualized peptide libraries for drug development, antibody characterization, and protein biomarker discovery.

PerformaNat GmbH was founded in 2015 as a spin-off of the veterinary medicine department of the Freie Universität Berlin. The first product – an animal-feed additive for use with dairy cows – was developed with the help of the EXIST Transfer of Research Grant Program of the German Federal Ministry for Economic Affairs and Energy, and it has already been successfully out-licenced. Further products are being developed.

Perora brought REDIA to market, the first effective medical food for the dietary management of diabetes type 2.

Phialogics is an innovative start-up in the field of autoimmune diseases. Founded in 2021 by a team of widely recognized experts in protein engineering and immunology, the company based in Basel (CH) and Heidelberg (GER) is committed to making a decisive contribution to the autoimmune disease space. The founding team is backed by strong Scientific Advisory and Supervisory Boards, which puts the company in a good position to move fast on the lead candidate and develop novel biologics.

Photonics Healthcare enables doctors to monitor cellular oxygen.

PicoLAS develops, manufactures and markets innovative, efficient and cost-effective power supplies for driving diode lasers and LEDs.

Pidoco develops a web-based rapid prototyping application for collaborative user interface design and efficient usability testing, enabling integration of all stakeholders during software development.

Plancraft enables craftspeople to focus on what they love. An extremely intuitive SaaS solution allows office work and teamwork to be maximally efficient. From project calculation to time tracking - basic processes are digitized and simplified for a chronically overworked workforce. For the first time, Plancraft combines the flexibility of the cloud with the specificity of industry software, setting a new standard.

Plasmion GmbH developed an „electronic nose sensor” based on mass spectrometry. This technology is not only revolutionizing chemical analysis in the laboratory environment, but is also intended to provide its performance in an automated sensor system for industrial applications.
Using SICRIT® ionization technology, it is now possible to perform trace analysis of solid, liquid or gaseous samples without any pre-treatment and in real-time. Plasmion’s products are thus used in medical diagnostics, environmental and food analysis as well as in emission monitoring.

PlastFormance develops, produces and markets unique polymer compounds for high-tech applications. The patented PlastFormance technology makes it possible to incorporate unprecedented amounts of ceramic and metallic fillers into a wide variety of plastics. PlastFormance materials differ fundamentally from competitor products in their unique combination of physical functionality (e.g. thermal conductivity or radiation protection), processability in injection molding and the use of spherical fillers. Prof. Dr. Dietmar Drummer, professor for plastics technology at the University of Erlangen-Nuremberg, supports the company as a scientific advisor.

With thousands of premium websites and over 40 million monthly visitors in the DACH region alone, plista is one of the most successful recommendation and ad networks in the German-speaking market. The company has developed a high-quality recommendation technology, which is used for the delivery of personalized reader recommendations as well as for advertisements. The company, founded in 2008, provides services to partners across all of Europe from its Berlin headquarters.

Exit since Dec. 2013. Purchaser: GROUPM Germany GmbH.

The Global Sourcing Platform provided by pliXos GmbH secures the quality of globally distributed software and IT services in an efficient and economic way. The customers benefit from enhanced transparency and control over the projects.

Exit since August 2016.

POSpulse is the leading crowd based Shopper Insights Intelligence company, providing leading industry segments with more transparency and excellence to better market their products and services. With a panel of mobile shoppers and the proprietary app “ShopScout” POSpulse generates insights along the entire customer decision journey: at home, out-of-home and directly at the point of experience (POE). Thanks to a state-of-the-art analytics dashboard, the results are analyzed by industry experts making sense of shopper data and providing real-time quality and actionable recommendations. Their customers include among others Mondelēz International, Mars Petcare, Media Markt, STORCK and Vodafone.

PraxisEins is a state-supported practice network with the aim of solving the impending GP care vacuum. In order to avert the structural undersupply in large parts of the country, the practice network creates attractive jobs in poorly supplied regions and helps with its own software solutions for practice administration and patient communication.

PreComb Therapeutics AG is a privately held Swiss biotech company founded in 2018 by Jens M. Kelm, Peter Steiner and Olivier Mauti with the aim of developing technologies that bring precision medicine benefits to all cancer patients. PreComb is pioneering breakthrough technologies to directly test the drug response of individual cancer patients, based on patient-derived 3D microtumors. For the first time, a fully automated point-of-care solution for determining drug sensitivity or resistance directly in the clinic is being developed. This offers the unique ability to routinely test entire portfolios of cancer drugs and drug combinations in large-scale, making the technology a universal tool from drug discovery to guiding therapies.

Predemtec focuses on the research, development and manufacture of innovative diagnostic tests for use in the detection of dementia-related risk factors. The first product, the Predemtec DX test, is a serum-based immunoassay and uses analysis algorithms for the early detection and risk diagnosis of senile dementia (Alzheimer’s type, AD).

PreOmics develops and provides innovative technologies for customers around the world for mass spectrometry (MS) - based proteomics using cutting-edge technologies to support researchers in their protein analysis needs.

Preventicus GmbH is developing smartphone-driven solutions to capture and analyze patients' vital parameters for early preclinical risk screening of lifestyle-related illnesses. Seed funding for the Jena-based company is managed by the German High-Tech Gründerfonds (HTGF) in Bonn and Born2Grow venture fund in Heilbronn. The capital is being provided to develop the products and portal to marketability.